Notes

MiMedx Announces Comprehensive Plank Refreshment Plan in Cooperation with Supposition Point
MARIETTA, Ga., May 30, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC RED: MDXG) ("MiMedx" or maybe the "Company"), an market leader in innovative wound care and an emerging restorative biologics company, nowadays announced that this Industry’s board of directors (the "Board") has adopted a comprehensive approach to refresh the particular composition of the Board. The approach was developed from the Board in cohesiveness with one of the Company's largest shareholders, Prescience Point Capital Management LLC ("Prescience Point"), plus follows the conclusion of the Exam Committee's independent exploration into alleged wrongdoing by the earlier senior management crew along with the engagement of BDO USA, LLP because the Company's new independent registered public accounting firm.

Underneath the plan, half a dozen new directors, like MiMedx's new TOP DOG, Timothy R. Wright, would be added to the Board. Therefore, Class II and even Class III from the Board would comprise entirely of fresh directors after the particular Company's 2019 gross annual meeting of shareholders. The refreshment program includes the scheduled appointment of three regarding Prescience Point's candidates, including M. Kathleen Behrens Wilsey, Ph. D. because the new Chairwoman in the Table, as well since K. Todd Newton, who will be expected in order to become the Chief of the Exam Committee after the particular Company's 2019 yearly meeting of investors.

"The MiMedx Plank and the present senior leadership crew have been functioning tirelessly to deal with the fallout by the actions of the prior senior supervision team and get the Company back in track, " mentioned Charles R. Evans, Chairman in the Board. "Now that we get produced substantial progress on these fronts, it is time to begin the Panel transition and refreshment process. Our company is thrilled to have worked collaboratively with Supposition Point to identify and even add new owners who bring outstanding experience and keep track of records to MiMedx. With the Exam Committee's investigation full and a strategy to refresh typically the Board set up, typically the Company is nowadays capable to focus about its future and even enhance its organization, for the gain of all stakeholders. "

"We encouraged the comprehensive want to refresh the Plank, and we seem forward to MiMedx's future under brand-new leadership. We are pleased that our own cooperation has lead in a reconstituted Board, with the addition of six new directors with valuable industry experience, relationships and reputational capital, " stated Eiad Asbahi, Originator and Managing Spouse of Prescience Level. "We invested within MiMedx because we all believe the Company offers immense potential since a leader inside advanced wound treatment and therapeutic biologics. We believe MiMedx is on the path to open substantial shareholder benefit and secure some sort of thriving future intended for the Company. inch

Under the refreshment plan, Prescience Level nominee M. Kathleen Behrens Wilsey, Ph. D. will get appointed or nominated for election in order to the Board in addition to is expected to be able to be named the new Chairwoman involving the Board. Dr . Behrens Wilsey is currently the Chairwoman of Sarepta Therapeutics, Incorporation. (SRPT), a multi-billion-dollar medical research plus drug development organization targeted on the finding and development of unique RNA-targeted therapeutics for the remedying of rare neuromuscular illnesses. Dr. Behrens Wilsey previously served on the boards of Amylin Pharmaceuticals, Inc. (formerly eiad asbahi prescience point ) and Abgenix, Inc. (formerly ABGX).

In addition in order to Dr. Behrens Wilsey, the Board can also appoint, or perhaps nominate for selection to the Table, Richard J. Barry, James L. Bierman, K. Todd Newton, Mr. Wright plus another director which will be hired by the Firm and Prescience Point. Complete biographies with the anticipated new owners appear at the particular end with this hit release.

The Company expects to file its preliminary web proxy materials for the 2018 Annual Meeting nowadays. The Board encourages shareholders to await to be able to receive the Industry’s proxy materials plus the Company's GLOWING BLUE proxy card prior to voting.

Sidley Austin texas LLP is acting as legal specialist to MiMedx. Olshan Frome Wolosky LLP is acting since legal advisor to Prescience Point.

About Richard J. Barry
Mr. Barry features served like a representative of Elcelyx Therapeutics, Inc., a private pharmaceutic company, since February 2013 and contains dished up as a Taking care of Member of GSM Fund, LLC, the fund established intended for the sole objective of investing found in Elcelyx Therapeutics, given that February 2013. Before in his career, he was a starting member of Eastbourne Capital Management LLC, a large fairness hedge fund trading in a selection of sectors, including healthcare, plus served as being the Taking care of General Partner and Portfolio Manager coming from 1999 to its close this season. Previous to that, he was a Portfolio Supervisor and Managing Representative of Robertson Stephens Investment Management, a great investment company, from 1995 until 1999. Ahead of that, Mr. Barry spent over 13 years in different roles in institutional equity and investment decision management firms, which include Lazard Freres, Legg Mason and Merrill Lynch. Mr. Craig has served because a director of Sarepta Therapeutics, Inc. (SRPT), a hereditary medicine company, since June 2015, in addition to he has recently been a Partner in addition to Advisory Board participant of the San Diego Padres since this year. Mr. Barry in the past served as a director of Chaos Wireless, LLC, a software company, by 2011 until 2014, and of BlackLight Power, Inc. (n/k/a Brilliant Light Energy, Inc. ), an energy research company, by 2009 until the new year. Mr. eiad asbahi prescience point keeps a B. A new. from Pennsylvania State University.

About Michael. Kathleen Behrens Wilsey, Ph. D.
Doctor Behrens Wilsey served as an associate of the board of directors of every of Sarepta Therapeutics, Inc. (SRPT), the multi-billion dollar health-related research and medication development company concentrated around the discovery plus development of unique RNA-targeted therapeutics for typically the treatment of exceptional neuromuscular diseases, due to the fact March 2009 (Chairwoman of the Panel since April 2015) and IGM Biosciences, Inc., an independently held biotechnology organization, since January 2019. Dr. Behrens Wilsey has worked being an independent life sciences consultant and buyer since December 2009. She served since the Co-Founder, President, Chief Executive Officer and as some sort of director of the KEW Group Incorporation., a private oncology services company, from January 2012 until June 2014. Earlier in her profession, Dr. Behrens Wilsey served as the general partner for selected venture money for RS Investments, a mutual fund firm, from 1996 until December year. While Dr. Behrens Wilsey worked with RS Investments, by 1996 to 2002, she served seeing that a managing overseer at the company and, from the year 2003 to December this year, she served like a consultant to the particular firm. During that time, Doctor Behrens Wilsey also offered as a participant from the President's Authorities of Advisors about Science and Technologies (PCAST), from i b?rjan p? tv?tusentalet to 2009 in addition to as chairwoman regarding PCAST's Subcommittee in Personalized Medicine, while well as the President, director plus chairwoman from the Country wide Venture Capital Relationship, an organization that will advocates for open public policy that supports the American Entrepreneurial ecosystem, from 1993 until 2000. Prior to that, your woman served like a complete partner and controlling director for Robertson Stephens & Co., an investment organization, from 1983 by means of 1996. She dished up as an overseer of Amylin Pharaceutical medication, Inc. (formerly AMLN), a biopharmaceutical business, from 2009 right up until the company's great deals in 2012 to be able to Bristol-Myers Squibb Corp. Prior to that will, she served upon the board of directors Abgenix, Incorporation. (formerly ABGX), a biopharmaceutical company, through 2001 before the organization was acquired by Amgen, Inc. in 2006. From 1997 to 2004, Dr. Behrens had been a director in the Board on Technology, Technology and Monetary Policy for the particular National Research Authorities. Doctor Behrens Wilsey seemed to be a Co-Founder with the Coalition with regard to modern world Medicine, a new trade association with regard to new generation diagnostics companies. Dr . Behrens Wilsey holds some sort of B. S. within Biology plus a Ph. D. in Microbiology from the University of California, Davis.

About James L. Bierman
Mr. Bierman served as Us president and Chief Business Officer of Owens & Minor, Incorporation., a Fortune five hundred company and the leading distributor of as well as surgical products, from September 2014 to June 2015. Previously, he served in several other more mature roles at Owens & Minor, which include President and Key Operating Officer from August 2013 to September 2014, Executive Vice President and Main Operating Officer by March 2012 in order to August 2013, Business Vp and Key Financial Officer by April 2011 in order to March 2012, and even Senior Vice Chief executive and Chief Economic Officer from August 2007 to 04 2011. From i b?rjan p? tv?tusentalet to 2004, Mister. Bierman served seeing that Executive Vp plus Chief Financial Officer at Quintiles Transnational Corp. Prior to becoming a member of Quintiles Transnational, Mister. Bierman was obviously a spouse at Arthur Andersen LLP. Mr. Bierman currently serves about the board of directors of Tenet Healthcare Corporation (THC) and previously dished up on the planks of directors regarding Owens & Minor, Inc. (OMI) in addition to Team Health Coalition, Inc. (formerly TMH). Mr. Bierman received his B. A new. from Dickinson College or university and his M. B. A. at Cornell University's Johnson Graduate School of Management.

About K. Jake Newton
Mr. Newton has, since 2014, served as Primary Executive Officer and a member of the board of administrators of Apollo Endosurgery, Inc. (APEN), a new leader in neuro-scientific stomach therapeutic endoscopy. By 2009 to 2014, Mr. Newton dished up as Executive Bassesse President and Main Financial Officer from ArthroCare Corporation (ARTC), a medical device company, including coming from 2013 as Chief Operating Officer. Prior to his leadership with ArthroCare, Mr. Newton served in a number of professional officer roles, which include President and Chief Executive Officer, at Synenco Energy, Inc., a Canadian oil sands organization. From 1994 in order to 2004, Mr. Newton was a Companion at Deloitte as well as Touche LLP. Mr. Newton holds some sort of B. B. Some sort of. in accounting through the University of Texas at San Antonio.

About Timothy R. Wright
Mr. Wright became MiMedx's Chief Executive Expert, effective as involving May 13, 2019. Previously, Mr. Wright served as a Partner at Signal Hillside Advisors, LLC, some sort of consulting practice, since February 2011. Mister. Wright served seeing that President and Primary Executive Officer regarding M2Gen Corp., a privately held cancer and health and fitness informatics company, in between July 2017 in addition to September 2018. Prior to M2Gen Corp., Mr. Wright served seeing that Executive Vice Chief executive, Mergers and Transactions, Strategy and Innovation for Teva Pharmaceutical drug Industries Ltd. ("Teva"), a pharmaceutical firm focusing on generic medications, from April 2015 until August 2017. Before Teva, Mr. Wright was the particular founding partner involving The Ohio Express University Comprehensive Tumor Drug Development Start. Mr. Wright also served as Chief, Interim Chief Exec Officer and a representative of Curaxis Pharmaceutical Corporation ("Curaxis"), the pharmaceutical company expert in the development of drugs with regard to the treatment regarding Alzheimer's disease in addition to various cancers, from July 2011 to July 2012. Curaxis was experiencing monetary difficulties prior to Mr. Wright's tenure and, as a result, typically the company filed for Chapter 11 individual bankruptcy in July the summer season. Mr. Wright has been a director of Agenus, Inc. (Nasdaq: AGEN), an immune oncology company, since 06 and its business lead director since 2009. Mr. Wright likewise is Chairperson of The Ohio Condition University Comprehensive Cancer Center Drug Growth Institute, serves as director of The Kansas State Innovation Foundation and sits for the Ohio State College College of Chemist Dean's Corporate Authorities. Mr. Wright earned a Bachelor's regarding Science in Advertising and marketing from The Kansas State University.

Concerning MiMedx
MiMedx� is an industry innovator in advanced twisted care and a good emerging therapeutic biologics company developing in addition to distributing human placental tissue allografts using patent-protected processes intended for multiple sectors involving healthcare. The business steps the human placental tissue utilizing its proprietary PURION� procedure methodology, among various other processes, to produce allografts by using aseptic processing techniques in addition to be able to terminal sterilization. MiMedx has supplied above 1 . 5 million allografts to time. For additional details, please visit www.mimedx.com.

About Prescience Stage Capital Management
Supposition Point Capital Management can be a private investment decision manager that utilizes forensic investigative strategies to unearth important mispricings in global markets. It specializes in extensive research of difficult-to-analyze open public companies in order to uncover important elements of the business enterprise that have recently been overlooked or overlooked by others.

Supposition Point manages private funds for the clients and principals and takes roles both long plus short supporting their research. Prescience Stage invests across a new broad set associated with equities that this believes have extraordinarily large disparities between what their base businesses are intrinsically worth and precisely what their securities offer for. The company was founded simply by investor Eiad Asbahi in 2009 and even is headquartered inside Baton Rouge, LOS ANGELES. Prescience Point Money Management is really an authorized investment advisor using the State regarding Louisiana. Follow @PresciencePoint.

Safe Harbor Assertion

This press launch includes forward-looking statements, including statements with regards to the plan of MiMedx Group, Inc. (the "Company") to refresh the Panel, the effects associated with such refreshment on the Company in addition to expectations with respect to Board leadership. Forward-looking eiad asbahi may be recognized by words like "believe, " "expect, " "may, very well "plan, " "potential, " "will, " "would" and comparable expressions and are usually based upon current values and expectations. Forward-looking statements are subject matter to risks plus uncertainties, as well as the Company cautions investors against placing undue dependence on such claims.

Actual results may possibly differ materially coming from those set out in the forward-looking transactions as a result of various factors, like the results of any election associated with Class II or even Class III directors. There is zero assurance that this Board's nominees will be selected at the Company's 2018 annual gathering of shareholders (the "2018 Annual Meeting") or the Carrier's 2019 annual gathering of shareholders. Just about any forward-looking statements communicate only as associated with the date regarding this press release, and except while required by rules, the Company presumes no obligation in order to update any forward-looking statement, whether as a result of new information, long term events or in any other case.

Information and facts
The Business intends to file a definitive proxy statement and associated ORANGE proxy card inside connection with typically the solicitation of proxies for that 2018 Gross annual Ending up in the Securities and Exchange Percentage (the "SEC"). Information concerning the nominees associated with the Company's board of directors intended for election at the 2018 Annual Meeting can be included in the proxy assertion. BEFORE MAKING VIRTUALLY ANY VOTING DECISION, SHAREHOLDERS OF THE FIRM ARE URGED IN ORDER TO READ ALL RELATED DOCUMENTS FILED WITH OR FURNISHED TO BE ABLE TO THE SEC, SUCH AS THE COMPANY'S DEFINITIVE WEB PROXY STATEMENT AND VIRTUALLY ANY SUPPLEMENTS THERETO, SINCE THEY WILL CONTAIN INFORMATION. Investors and investors will be capable to obtain some sort of copy of typically the definitive proxy statement and other documents filed by typically the Company free involving charge from the SEC's website at www.sec.gov. The Company's shareholders is likewise capable to obtain, without charge, a copy involving the definitive web proxy statement and also other relevant filed documents through the "SEC Filings" section of typically the Company's website from www.mimedx.com.

Participants found in the Solicitation
The Company, its directors, it is director nominees in addition to certain of it is executive officers are generally participants in the solicitation of unblock proxies from shareholders found in respect of typically the 2018 Annual Gathering. Information regarding the names in the Industry’s directors, director nominees and executive representatives and their respected interests in typically the Company by protection holdings or or else is set up in the Provider's Current Report in Form 8-K filed with the SEC upon May 30, 2019. Additional information about the interests of these kinds of participants in any proxy solicitation and even a description of their direct and roundabout interests, by safety measures holdings or else, will certainly also be incorporated in any serwery proxy statement and also other relevant materials to get submitted with the SECURITIES AND EXCHANGE COMMISSION'S, if and if they become obtainable.
My Website: https://dailyuploads.net/ev8fwckp8bml